Avation Medical has developed the Vivally® System, a wearable physiologic closed-loop neuromodulation device that utilizes transcutaneous tibial nerve stimulation to treat overactive bladder (OAB) symptoms at home. This FDA-cleared system allows patients to manage urinary urgency and urge urinary incontinence with just 30 minutes of use, one to three times a week, while tracking their progress through a mobile application.
Funding
$38.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Overactive bladder (OAB) and urge urinary incontinence significantly impact quality of life, affecting millions. Traditional treatments often involve medications with potential side effects or invasive procedures, creating a need for non-pharmacological, accessible solutions. Many patients lack convenient options for managing their symptoms effectively at home.
Solution
The Vivally System offers a wearable, at-home solution for managing OAB symptoms using physiologic closed-loop neuromodulation. This FDA-cleared system utilizes transcutaneous tibial nerve stimulation (TTNS) to automatically optimize therapeutic output in real time. Patients wear the SmartSense Wrap on their ankle for 30 minutes, one to three times a week, while the CliQ Stimulator delivers targeted therapy. The MyVivally mobile app tracks treatment progress and provides comprehensive patient support.
Target Audience
The primary target audience includes individuals experiencing overactive bladder (OAB) and urge urinary incontinence, as well as healthcare providers seeking a non-pharmacological treatment option for their patients.
Features
- Wearable SmartSense Wrap for easy at-home application
- CliQ Stimulator for delivering physiologic closed-loop TTNS
- MyVivally mobile app for treatment tracking, patient support, and progress monitoring
- Personalized therapy calibrated to individual patient needs during a single office visit
- Remote patient monitoring capabilities for healthcare providers
- Non-invasive, drug-free OAB treatment